The Board denied a compensable disability rating for the Veteran's residuals of bladder cancer, as the symptoms were attributed to non-service-connected benign prostatic hyperplasia.
The deciding factor: The November 2024 opinion concluded that the Veteran's urinary symptoms were due to his non-service connected BPH and not his service-connected residuals of bladder cancer.
- Claimed conditions
- Bladder cancer residuals
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- April 7, 2025
- Citation
- 25004704
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board denied a higher rating for the residuals of bladder cancer but granted an earlier effective date for service connection.
- Partly granted
The Board granted a disability rating of 100 percent from July 1, 2023, to July 31, 2023, for service-connected bladder cancer residuals and denied a compensable disability rating from August 1, 2023.
- Remanded (sent back)
The Board remands the matter to obtain private treatment records and a retrospective opinion regarding the manifestations of the Veteran's bladder cancer residuals.
- Dismissed
The appeals for increased ratings and service connection were dismissed due to untimely filings.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.